Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial
- PMID: 40294124
- PMCID: PMC12036954
- DOI: 10.1111/ctr.70166
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial
Abstract
Background: The role of machine perfusion after kidney transplantation (KT) in extended criteria donors (ECD) is unclear, and the current evidence in the literature remains controversial.
Methods: We present an open-label single center randomized trial where 109 patients undergoing KT with ECD grafts between January 2019 and December 2022 were randomized to receive kidneys treated with either hypothermic oxygenated perfusion (HOPE, n = 54) or static cold storage (SCS, n = 55) alone. The primary endpoint was the incidence of delayed graft function (DGF). The secondary endpoints included postoperative complications and graft function and survival in the first year after KT.
Results: The trial failed to meet its primary endpoint. DGF developed in 31 (57%) and 37 (67%) patients in the HOPE and SCS groups, respectively (p = 0.3). Posthoc analysis showed that HOPE was associated with a lower risk for DGF for grafts from donors aged 60 years or older (OR 0.32, 95% CI 0.12-0.87, p = 0.026) and in patients undergoing dual KTs (OR 0.22, 95% CI 0.06-0.87, p = 0.031).
Conclusions: HOPE does not reduce the rate of DGF after KT in ECD donors. However, HOPE appears to be associated with better outcomes in the case of older donors and dual KTs.
Keywords: delayed graft function; extended criteria donors; graft survival; kidney transplantation; machine perfusion.
© 2025 The Author(s). Clinical Transplantation published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation.Cochrane Database Syst Rev. 2019 Mar 15;3(3):CD011671. doi: 10.1002/14651858.CD011671.pub2. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2024 Jul 9;7:CD011671. doi: 10.1002/14651858.CD011671.pub3. PMID: 30875082 Free PMC article. Updated.
-
Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded criteria donors.Clin Transplant. 2019 May;33(5):e13536. doi: 10.1111/ctr.13536. Epub 2019 Apr 10. Clin Transplant. 2019. PMID: 30869162
-
Short (2-Hour) Non-Oxygenated End-Ischemic Hypothermic Perfusion Versus Cold Storage in the Setting of Renal Transplantation.Artif Organs. 2025 May;49(5):831-841. doi: 10.1111/aor.14953. Epub 2025 Jan 24. Artif Organs. 2025. PMID: 39861988 Free PMC article.
-
Hypothermic machine perfusion can safely prolong cold ischemia time in deceased donor kidney transplantation. A retrospective analysis on postoperative morbidity and graft function.Artif Organs. 2021 May;45(5):516-523. doi: 10.1111/aor.13858. Epub 2021 Jan 8. Artif Organs. 2021. PMID: 33210745
-
Hypothermic Machine Perfusion Versus Static Cold Storage in Deceased Donor Kidney Transplantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Artif Organs. 2019 May;43(5):478-489. doi: 10.1111/aor.13364. Epub 2018 Nov 9. Artif Organs. 2019. PMID: 30282122
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical